In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease.
AUTOR(ES)
Chiodini, R J
RESUMO
The in vitro susceptibility of three strains of an unclassified Mycobacterium sp., isolated from three patients with Crohn's disease, to 23 antimicrobial agents was determined by a modified broth dilution method with 7H9 broth containing oleic acid-albumin-dextrose-catalase, Tween 80, and mycobactin J. All three strains were susceptible to streptomycin, viomycin, rifampin, clofazimine, cefazolin, amikacin, and kanamycin and resistant to p-aminosalicylic acid, cycloserine, 2-thiophenecarboxylic acid hydrazide, trimethoprim, diaminodiphenylsulfone, sulfamethoxazole, sulfadimethoxine, polymyxin B, metronidazole, neomycin, and carbenicillin. Variable results between strains were encountered with ethambutol, ethionamide, capreomycin, amoxicillin, and cephalothin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180053Documentos Relacionados
- Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease.
- Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.
- Seroprevalence of Mycobacterium paratuberculosis in Patients with Crohn's Disease
- Ocular disorders in a series of 332 patients with Crohn's disease.
- Neurochemical coding in the small intestine of patients with Crohn's disease.
